secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zentalis Pharmaceuticals, Inc. (ZNTL)
CIK:        0001725160
Form:       8-K
Filed at:   2023-09-13T23:59:59+00:00
Accession:  0001725160-23-000161
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zentalis Pharmaceuticals furnishes corporate presentation; no specific new data disclosed in excerpt
--------------------------------------------------------------------------------

- Presentation dated September 2023 will be used in investor meetings and conferences.
- No financial results, pipeline updates, or guidance changes are available from the provided exhibit excerpt.
- Filing under Regulation FD; information is furnished, not filed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725160/000172516023000161/0001725160-23-000161-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725160/000172516023000161/zntl-20230913.htm
  HTML page:      https://secwatch.observer/filing/0001725160-23-000161

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer